Lonza Group’s carve-out takes an important first step, adding to its strength as a provider of microbial control solutions.
David Savastano, editor-in-chief12.16.21
In July 2021, Lonza Specialty Ingredients (LSI) was successfully separated from the Lonza Group. Backed by Herens HoldCo Ltd., an entity controlled by private equity firms Bain Capital and Cinven, LSI will soon be renamed Arxada. The company has two key business segments: Microbial Control Solutions (MCS) and Specialty Product Solutions (SPS). The plan is to grow on two fronts: strategic mergers and acquisitions opportunities and internal investments. In its first big step, Arxada announced on November 3, 2021 that it is partnering with Troy Corporation, a global leader in microbial control solutions and performance additives. Financial details of the deal were not disclosed, although as part of the deal the owners of Troy will invest in the combined company. The parties will endeavor to conclude the transaction as soon as possible, subject to obtaining the authorizations for use. The combined company will have a strengthened product portfolio in a range of markets, including paints and coatings, woo